You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fuch's endothelial dystrophy

Showing 1 - 25 of 4,047
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fuchs' Endothelial Dystrophy Trial in Glenview (Ripasudil HCl hydrate 0.4% ophthalmic solution)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Ripasudil hydrochloride hydrate 0.4% ophthalmic solution
  • Glenview, Illinois
    NorthShore University HealthSystem
Aug 9, 2021

Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy Trial (DSAEK, DMEK)

Not yet recruiting
  • Corneal Edema
  • +4 more
  • DSAEK
  • DMEK
  • (no location specified)
Jun 29, 2022

Fuchs' Endothelial Dystrophy, Cataract Trial in Singapore (Ripasudil, Placebo)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Cataract
  • Singapore, Singapore
    Singapore National Eye Centre
Sep 15, 2023

Fuchs, Fuchs Dystrophy, Fuchs' Endothelial Dystrophy Trial in United States (Ripasudil, Placebo)

Recruiting
  • Fuchs
  • +2 more
  • Palo Alto, California
  • +3 more
Jan 30, 2023

Fuchs' Corneal Endothelial Dystrophy in France

Not yet recruiting
  • Corneal Dystrophies
  • Genotyping
  • +2 more
  • Saint-Étienne, France
    Centre Hospitalier de Saint-Etienne
Feb 22, 2023

Fuchs Endothelial Corneal Dystrophy Trial (Ripasudil, Placebo)

Not yet recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • (no location specified)
Apr 21, 2023

Fuchs Endothelial Corneal Dystrophy Trial in Kansas City, Portland (Ripasudil, Placebo)

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • Kansas City, Missouri
  • +1 more
Apr 5, 2023

Fuchs Endothelial Corneal Dystrophy Trial in Indianapolis, Houston (STN1010904 ophthalmic suspension 0.03% BID, STN1010904

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • STN1010904 ophthalmic suspension 0.03% BID
  • +2 more
  • Indianapolis, Indiana
  • +7 more
Jan 31, 2023

Fuchs' Endothelial Dystrophy Trial in Freiburg (Supine positioning: 5 days, Supine positioning: 1 days)

Not yet recruiting
  • Fuchs' Endothelial Dystrophy
  • Supine positioning: 5 days
  • Supine positioning: 1 days
  • Freiburg, Baden-Wuerttemberg, Germany
    Medical Center - University of Freiburg, Eye Hospital
May 31, 2022

Test Diagnostic Potential of Brillouin Microscopy for Corneal

Recruiting
  • Keratoconus
  • +3 more
  • Brillouin imaging
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 30, 2022

Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen

Recruiting
  • Fuchs Dystrophy
    • Buffalo, New York
      The Ira G. Ross Eye Institute
    Apr 1, 2022

    Corneal Endothelial Decompensation, Fuchs' Endothelial Dystrophy Trial in Indianapolis, Grand Rapids (Descemet membrane

    Recruiting
    • Corneal Endothelial Decompensation
    • Fuchs' Endothelial Dystrophy
    • Descemet membrane endothelial keratoplasty
    • Indianapolis, Indiana
    • +1 more
    Oct 3, 2022

    Fuchs' Endothelial Dystrophy Trial in Boston (Netarsudil Ophthalmic)

    Recruiting
    • Fuchs' Endothelial Dystrophy
    • Netarsudil Ophthalmic
    • Boston, Massachusetts
      Massachusetts Eye and Ear Infirmary
    Aug 23, 2022

    Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases Trial in London (QR-504a)

    Withdrawn
    • Fuchs Endothelial Corneal Dystrophy
    • +4 more
    • London, United Kingdom
      Moorfields Eye Hospital, NIHR Clinical Research Facility
    May 5, 2022

    Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,

    Not yet recruiting
    • Pseudophakic Bullous Keratopathy
    • +2 more
    • Fluorometholone 0.1% Oph Susp
    • +2 more
    • (no location specified)
    Feb 7, 2023

    Fuchs' Endothelial Dystrophy Trial in Vienna (Ultrahigh resolution Spectral Domain OCT)

    Completed
    • Fuchs' Endothelial Dystrophy
    • Ultrahigh resolution Spectral Domain OCT
    • Vienna, Austria
    • +1 more
    Apr 6, 2022

    Fuchs' Corneal Endothelial Dystrophy in France.

    Completed
    • Fuchs Endothelial Corneal Dystrophy
    • Collection of datas
    • +2 more
    • Saint-Étienne, France
      Chu Saint-Etienne
    Dec 29, 2021

    Fuchs' Endothelial Corneal Dystrophy Trial in Worldwide (K-321 Solution, Placebo Solution)

    Completed
    • Fuchs' Endothelial Corneal Dystrophy
    • K-321 Solution
    • Placebo Solution
    • Los Angeles, California
    • +28 more
    Sep 20, 2022

    Corneal Edema, Corneal Endothelial Dystrophy, Endothelial Dysfunction Trial in Mexico City (EO2002, Ripasudil)

    Recruiting
    • Corneal Edema
    • +7 more
    • Mexico City, Cdmx, Mexico
      Asociacion para Evitar la Ceguera en Mexico
    Dec 1, 2022

    Fuchs Endothelial Dystrophy Trial in Indianapolis (Netarsudil Ophthalmic Solution, Placebo)

    Completed
    Has Results
    • Fuchs Endothelial Dystrophy
    • Netarsudil Ophthalmic Solution
    • Placebo
    • Indianapolis, Indiana
      Price Vision Group
    Sep 23, 2021

    OCT in Fuchs' Dystrophy

    Recruiting
    • Fuchs Dystrophy
    • Pseudophakic Bullous Keratopathy
      • Portland, Oregon
        Oregon Health & Science University
      Sep 21, 2021

      Fuchs Endothelial Dystrophy Trial in Portland (Glanatec, Optive, Ophthalmic Solution, Descemet Membrane Endothelial

      Recruiting
      • Fuchs Endothelial Dystrophy
      • Portland, Oregon
        Devers Eye Institute
      Sep 2, 2021

      Fuchs Dystrophy, Cataract Trial in Town And Country (BSS Plus, BSS)

      Recruiting
      • Fuchs Dystrophy
      • Cataract
      • Town And Country, Missouri
        St. Louis Eye Institute
      May 11, 2023

      Fuchs' Endothelial Dystrophy Trial in Indianapolis (Netarsudil, Placebo)

      Terminated
      • Fuchs' Endothelial Dystrophy
      • Indianapolis, Indiana
        Price Vision Group
      Aug 28, 2021

      Corneal Endothelial Dystrophy, Corneal Edema Trial in Indianapolis (loteprednol etabonate 0.25% ophthalmic suspension)

      Active, not recruiting
      • Corneal Endothelial Dystrophy
      • Corneal Edema
      • loteprednol etabonate 0.25% ophthalmic suspension
      • Indianapolis, Indiana
        Price Vision Group
      Jan 6, 2023